Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients

It was recently reported that rs1541160 on chromosome 1q24.2 has a marked effect on survival of amyotrophic lateral sclerosis (ALS) patients by influencing KIFAP3 expression. The cohorts used in that study were collected from ALS specialty clinics. We attempted to replicate these findings in a population-based cohort of 504 Italian ALS patients. None of 140 SNPs genotyped within the KIFAP3 locus (including rs1541160) had an effect on survival (log-rank P value for rs1541160 = 0.47) or on gene expression in that region. These data illustrate the complexities associated with analyzing ALS phenotypes for association.

[1]  Luigi Ferrucci,et al.  Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human Brain , 2010, PLoS genetics.

[2]  Michael Boehnke,et al.  Quantifying and correcting for the winner's curse in genetic association studies , 2009, Genetic epidemiology.

[3]  Claire L. Simpson,et al.  Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis , 2009, Proceedings of the National Academy of Sciences.

[4]  Sonja W. Scholz,et al.  A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. , 2009, Human molecular genetics.

[5]  E. Beghi,et al.  Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[6]  A. Al-Chalabi,et al.  Genetic studies of amyotrophic lateral sclerosis: Controversies and perspectives , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[7]  M. Stephens,et al.  High-Resolution Mapping of Expression-QTLs Yields Insight into Human Gene Regulation , 2008, PLoS genetics.

[8]  John D. Storey,et al.  Mapping the Genetic Architecture of Gene Expression in Human Liver , 2008, PLoS biology.

[9]  D. Stephan,et al.  A survey of genetic human cortical gene expression , 2007, Nature Genetics.

[10]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[11]  A. Chiò,et al.  Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  E. Beghi,et al.  Survival of Patients with Amyotrophic Lateral Sclerosis in a Population-Based Registry , 2005, Neuroepidemiology.

[13]  Adriano Chiò,et al.  Acute migraine treatment with droperidol , 2003, Neurology.

[14]  O. Hardiman,et al.  Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000 , 2003, Journal of neurology, neurosurgery, and psychiatry.

[15]  T D Koepsell,et al.  Prognosis in amyotrophic lateral sclerosis , 2003, Neurology.

[16]  J. Annegers,et al.  Prognosis of amyotrophic lateral sclerosis and the effect of referral selection , 1995, Journal of the Neurological Sciences.

[17]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[18]  J. Slattery,et al.  The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register , 1993, Journal of Neurology.

[19]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[20]  Mulder Dw.  Clinical limits of amyotrophic lateral sclerosis. , 1982 .